Cargando…
Deletions in the 17q chromosomal region and their influence on the clonal cytogenetic evolution of recurrent meningiomas
OBJECTIVE: Meningiomas are among the most frequent intracranial tumors. Although the majority of meningiomas can be cured by surgical resection, up to 20% of the patients develop an aggressive clinical course with tumor recurrence or progressive disease. Cytogenetically, meningiomas frequently harbo...
Autores principales: | Hemmer, Sina, Urbschat, Steffi, Oertel, Joachim, Ketter, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534836/ https://www.ncbi.nlm.nih.gov/pubmed/31139260 http://dx.doi.org/10.1186/s13039-019-0434-4 |
Ejemplares similares
-
Establishment of a molecular cytogenetic analysis for native tumor tissue of meningiomas-suitable for clinical application
por: Lerner, Cornelia, et al.
Publicado: (2014) -
Molecular Biological Determinations of Meningioma Progression and Recurrence
por: Linsler, Stefan, et al.
Publicado: (2014) -
MicroRNA 200a as a histologically independent marker for meningioma recurrence: Results of a four microRNA panel analysis in meningiomas
por: Urbschat, Steffi, et al.
Publicado: (2022) -
Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy
por: Urbschat, Steffi, et al.
Publicado: (2017) -
Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas
por: Sippl, Christoph, et al.
Publicado: (2018)